AbbVie ABBV Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.
The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbbVie's debt issuance proceeds?
- AbbVie (ABBV) reported debt issuance proceeds of $7.99B in Q1 2026.
- How has AbbVie's debt issuance proceeds changed year-over-year?
- AbbVie's debt issuance proceeds increased by 100.1% year-over-year, from $3.99B to $7.99B.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.